FOXO TECHNOLOGIES INC. Accounts Receivable, Held-for-sale
FOXO TECHNOLOGIES INC. (FOXO) had Accounts Receivable, Held-for-sale of $200.00 thousand as of 2025-12-31, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › and Others
us-gaap:TradeReceivablesHeldForSaleAmount · last filed 2026-08-14
- 2025-12-31: Accounts Receivable, Held-for-sale $200.00K; Accounts Receivable, Held-for-sale as first filed $400.00K.
| Period end | Accounts Receivable, Held-for-sale | Accounts Receivable, Held-for-sale as first filed |
|---|---|---|
| 2025-12-31 | $200.00K 10-Q · filed 2026-08-14 | $400.00K 10-K · filed 2026-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |